Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification (2021)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.17.21255471
Publication URI: http://dx.doi.org/10.1101/2021.04.17.21255471
Type: Preprint